Growing community of inventors

Durham, NC, United States of America

Michael John Alberti

Average Co-Inventor Count = 4.09

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 8

Michael John AlbertiDavid Kendall Jung (3 patents)Michael John AlbertiBrian Alvin Johns (2 patents)Michael John AlbertiMui Cheung (2 patents)Michael John AlbertiPaul Bamborough (2 patents)Michael John AlbertiPhilip Anthony Harris (2 patents)Michael John AlbertiStanley Dawes Chamberlain (2 patents)Michael John AlbertiKristjan S Gudmundsson (2 patents)Michael John AlbertiDavid Harold Drewry (2 patents)Michael John AlbertiDavid Drysdale Miller (2 patents)Michael John AlbertiMichael Robert Peel (2 patents)Michael John AlbertiJennifer Badiang Stanford (2 patents)Michael John AlbertiMichael John Alberti (5 patents)David Kendall JungDavid Kendall Jung (15 patents)Brian Alvin JohnsBrian Alvin Johns (55 patents)Mui CheungMui Cheung (43 patents)Paul BamboroughPaul Bamborough (26 patents)Philip Anthony HarrisPhilip Anthony Harris (26 patents)Stanley Dawes ChamberlainStanley Dawes Chamberlain (20 patents)Kristjan S GudmundssonKristjan S Gudmundsson (19 patents)David Harold DrewryDavid Harold Drewry (12 patents)David Drysdale MillerDavid Drysdale Miller (12 patents)Michael Robert PeelMichael Robert Peel (9 patents)Jennifer Badiang StanfordJennifer Badiang Stanford (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Smithkline Beecham Corporation (4 from 2,198 patents)

2. Glaxosmithkline LLC (1 from 356 patents)


5 patents:

1. 7888503 - Benzodiazepine derivatives that inhibit rock

2. 7598251 - Aminopyrazine derivatives and compositions

3. 7459454 - Aminopyrazine derivatives and compositions

4. 7109209 - Pyrazolopyridines, process for their preparation and use as therapeutic compounds

5. 7034030 - Pyralopyridines, process for their preparation and use as therapeutic compounds

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…